CONTROL KIT, BLOOD GROUPING SERUM AND RED

Solicitation SPE2DS-26-T-430T is a request for quotations issued by the DLA Troop Support Medical Supply Chain for four units of the Ortho Confidence blood grouping serum and red blood cell control kit, identified by NSN 6550-01-279-5285. The kit is designed to confirm the reactivity of reagents used for ABO and Rh determinations, including anti-human globulin and antibody detection tests. Each kit must contain two 10 ml cells and two 8 ml antibodies. This Class II FDA-regulated device requires the supplier to meet specific marketing requirements, including registration, listing, and labeling or GMP compliance. The contract imposes strict quality and logistics requirements, including mandatory refrigeration between 2 and 8 degrees Celsius and a non-extendable shelf life of one month. To ensure freshness, no more than five days may elapse between the date of manufacture and delivery to the government. Packaging must be commercial and adhere to Medical Marking Standard No. 1, while hazardous materials must comply with 29 C.F.R. 1910.1200, requiring the submission of Safety Data Sheets and HCS labels prior to award. Delivery is required by September 16, 2026, to the Naval Medical Readiness Logistics Command in Williamsburg, Virginia, with inspection and acceptance occurring at the destination. Offerors must submit quotes via the DIBBS system, providing a complete data package that specifies the source and part numbers for both approved and alternate parts.